Rejuvenate Bio is a startup that is working on reversing aging in dogs and then will try to reverse aging in humans. George Church is a Harvard Professor -serial entrepreneur of many multi-million dollar and even billion dollar biotech companies.
Aging reversal test in dog trials in 2018-2019. Human trials would be in 2019-2022 and about 2025 before they are done. Once you get a few going and succeeding it’s a positive feedback loop.
Rejuvenate Bio has carried out preliminary tests on beagles, claims it will make animals “younger” by adding new DNA instructions to their bodies.
“We have already done a bunch of trials in mice and we are doing some in dogs, and then we’ll move on to humans,” Church told the podcaster Rob Reid earlier this year. The company’s other founders are CEO Daniel Oliver and science lead Noah Davidsohn, a postdoc in Church’s sprawling Boston lab.
The US pet industry is a $72-billion-a-year market.
The prolongation of human lifespan is “the biggest thing that is going to happen in the 21st century,” says David Sinclair, a Harvard biologist who collaborates with the Church lab. “It’s going to make what Elon Musk is doing look fairly pedestrian.”